Literature DB >> 27544642

Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better.

Katharine Ea Darling1, Anna Hachfeld2, Matthias Cavassini1, Ole Kirk3, Hansjakob Furrer2, Gilles Wandeler4.   

Abstract

In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), of whom 17.1 million did not know they were infected. Whilst the number of new human immunodeficiency virus (HIV) infections has declined globally since 2000, there are still regions where new infection rates are rising, and diagnosing HIV early in the course of infection remains a challenge. Late presentation to care in HIV refers to individuals newly presenting for HIV care with a CD4 count below 350 cells/µl or with an acquired immune deficiency syndrome (AIDS)-defining event. Late presentation is associated with increased patient morbidity and mortality, healthcare costs and risk of onward transmission by individuals unaware of their status. Further, late presentation limits the effectiveness of all subsequent steps in the cascade of HIV care. Recent figures from 34 countries in Europe show that late presentation occurs in 38.3% to 49.8% of patients newly presenting for care, depending on region. In Switzerland, data from patients enrolled in the Swiss HIV Cohort Study put the rate of late presentation at 49.8% and show that patients outside established HIV risk groups are most likely to be late presenters. Provider-initiated testing needs to be improved to reach these groups, which include heterosexual men and women and older patients. The aim of this review is to describe the scale and implications of late presentation using cohort data from Switzerland and elsewhere in Europe, and to highlight initiatives to improve early HIV diagnosis. The importance of recognising indicator conditions and the potential for missed opportunities for HIV testing is illustrated in three clinical case studies.

Entities:  

Mesh:

Year:  2016        PMID: 27544642     DOI: 10.4414/smw.2016.14348

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  16 in total

1.  Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis.

Authors:  Sharon Weissman; Xueying Yang; Jiajia Zhang; Shujie Chen; Bankole Olatosi; Xiaoming Li
Journal:  AIDS       Date:  2021-05-01       Impact factor: 4.177

2.  Late presentation of chronic viral hepatitis for medical care: a consensus definition.

Authors:  Stefan Mauss; Stanislas Pol; Maria Buti; Erika Duffell; Charles Gore; Jeffrey V Lazarus; Hilje Logtenberg-van der Grient; Jens Lundgren; Antons Mozalevskis; Dorthe Raben; Eberhard Schatz; Stefan Wiktor; Jürgen K Rockstroh
Journal:  BMC Med       Date:  2017-05-03       Impact factor: 8.775

3.  Patient and doctor perspectives on HIV screening in the emergency department: A prospective cross-sectional study.

Authors:  Noemy De Rossi; Nicolas Dattner; Matthias Cavassini; Solange Peters; Olivier Hugli; Katharine E A Darling
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

4.  Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study.

Authors:  Ni Gusti Ayu Nanditha; Martin St-Jean; Hiwot Tafessu; Silvia A Guillemi; Mark W Hull; Michelle Lu; Bonnie Henry; Rolando Barrios; Julio S G Montaner; Viviane D Lima
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

5.  Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020.

Authors:  Nadine Mayasi Ngongo; Hippolyte Situakibanza Nani-Tuma; Marcel Mbula Mambimbi; Murielle Longokolo Mashi; Ben Bepouka Izizag; Faustin Kitetele Ndolumingu; Nathalie Maes; Michel Moutschen; Gilles Darcis
Journal:  AIDS Res Ther       Date:  2021-07-16       Impact factor: 2.250

6.  Late presentation for HIV care in Southwest Ethiopia in 2003-2015: prevalence, trend, outcomes and risk factors.

Authors:  Hailay Abrha Gesesew; Paul Ward; Kifle Woldemichael; Lillian Mwanri
Journal:  BMC Infect Dis       Date:  2018-01-30       Impact factor: 3.090

7.  Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.

Authors:  I Poizot-Martin; V Obry-Roguet; C Duvivier; C Lions; T Huleux; C Jacomet; T Ferry; A Cheret; C Allavena; F Bani-Sadr; R Palich; A Cabié; A Fresard; P Pugliese; P Delobel; I Lamaury; L Hustache-Mathieu; S Brégigeon; A Makinson; D Rey
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-04-30       Impact factor: 6.166

8.  Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.

Authors:  Tosca Lazzarino; Sebastien Martenet; Rachel Mamin; Renaud A Du Pasquier; Solange Peters; Matthieu Perreau; Olivier Muller; Olivier Hugli; Matthias Cavassini; Katharine Elizabeth Anna Darling
Journal:  BMJ Open       Date:  2018-10-03       Impact factor: 2.692

9.  Duration of Human Immunodef iciency Virus Infection at Diagnosis among New Human Immunodef iciency Virus Cases in Dehong, Yunnan, China, 2008-2015.

Authors:  Ai-Hua Li; Zun-You Wu; Zhen Jiang; Jennifer M McGoogan; Yan Zhao; Song Duan
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

10.  Missed opportunities for HIV testing among patients newly presenting for HIV care at a Swiss university hospital: a retrospective analysis.

Authors:  Loïc Lhopitallier; Estelle Moulin; Olivier Hugli; Matthias Cavassini; Katharine Elizabeth Anna Darling
Journal:  BMJ Open       Date:  2018-06-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.